Cash flow Sekisui Chemical Co., Ltd.

Equities

4204

JP3419400001

Homebuilding

Market Closed - Japan Exchange Other stock markets 06:30:00 12/02/2026 GMT			5-day change	1st Jan Change
2,970.50 ^JPY	+0.71%		+5.52%	+12.73%

02-09	Sekisui Chemical Co., Ltd.'s Equity Buyback announced on October 30, 2025, has closed with 10,000,000 shares, representing 2.43% for ¥26,420.48 million.	CI
02-09	Tranche Update on Sekisui Chemical Co., Ltd.'s Equity Buyback Plan announced on October 30, 2025.	CI

00ec.I7uOkJsoqXYDMfLg7j3Iz3cvx8Ud2Ui9_3y1ebhhzjI.Ucjtyv9xwwx3dMuknFusrjN-lIAouGXezwvtFusXmVlg1sLWy0vDMGRZow

Published financial data: SEKISUI CHEMICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1,057B	1,158B	1,243B	1,257B	1,298B
Total Revenues	1,057B	1,158B	1,243B	1,257B	1,298B
Cost of Goods Sold, Total	726B	802B	865B	864B	877B
Gross Profit	330B	356B	377B	392B	421B
Selling General & Admin Expenses, Total	213B	216B	230B	240B	252B
Provision for Bad Debts	162M	135M	-31M	215M	158M
R&D Expenses	35.11B	37.01B	40.47B	41.7B	44.25B
Depreciation & Amortization - (IS)	14.67B	14.12B	14.94B	16.2B	16.47B
Other Operating Expenses, Total	263B	267B	286B	298B	313B
Operating Income	67.3B	88.88B	91.67B	94.4B	108B
Interest Expense, Total	-861M	-774M	-871M	-1.1B	-1.04B
Interest And Investment Income	4.85B	4.36B	4.89B	5.46B	5.39B
Net Interest Expenses	3.99B	3.58B	4.02B	4.35B	4.36B
Income (Loss) On Equity Invest.	2.75B	108M	2.25B	843M	-1.09B
Currency Exchange Gains (Loss)	543M	4.82B	5.2B	6.96B	-411M
Other Non Operating Income (Expenses)	-11.94B	-387M	1.82B	-210M	2.08B
EBT, Excl. Unusual Items	62.65B	97B	105B	106B	113B
Gain (Loss) On Sale Of Investments	1.53B	25.91B	-130M	11.46B	14.06B
Gain (Loss) On Sale Of Assets	1.43B	-1.54B	-2.17B	-1.77B	-2.25B
Asset Writedown	-2.43B	-51.51B	-3.15B	-4.55B	-4.71B
Other Unusual Items	0	-	-2M	1M	-1M
EBT, Incl. Unusual Items	63.18B	69.86B	99.49B	111B	120B
Income Tax Expense	19.9B	31.1B	28.73B	32.42B	35.87B
Earnings From Continuing Operations	43.28B	38.76B	70.77B	79.05B	84.11B
Net Income to Company	43.28B	38.76B	70.77B	79.05B	84.11B
Minority Interest	-1.73B	-1.69B	-1.5B	-1.12B	-2.18B
Net Income - (IS)	41.54B	37.07B	69.26B	77.93B	81.92B
Net Income to Common Incl Extra Items	41.54B	37.07B	69.26B	77.93B	81.92B
Net Income to Common Excl. Extra Items	41.54B	37.07B	69.26B	77.93B	81.92B
Per Share Items
Net EPS - Basic	91.92	83.17	159.19	183.48	195.93
Basic EPS - Continuing Operations	91.92	83.17	159.19	183.48	195.93
Basic Weighted Average Shares Outstanding	452M	446M	435M	425M	418M
Net EPS - Diluted	91.92	83.17	159.19	183.48	195.93
Diluted EPS - Continuing Operations	91.92	83.17	159.19	183.48	195.93
Diluted Weighted Average Shares Outstanding	452M	446M	435M	425M	418M
Normalized Basic EPS	82.8	132.23	147.3	153.85	163.51
Normalized Diluted EPS	82.8	132.23	147.3	153.85	163.51
Dividend Per Share	47	49	59	74	79
Payout Ratio	50.43	58.09	34.38	35.71	38.98
American Depositary Receipts Ratio (ADR)	5	5	5	5	5
Supplemental Items
EBITDA	117B	138B	144B	147B	162B
EBITA	71.72B	91.67B	95.08B	95.88B	109B
EBIT	67.3B	88.88B	91.67B	94.4B	108B
Effective Tax Rate - (Ratio)	31.5	44.52	28.87	29.09	29.9
Normalized Net Income	37.42B	58.93B	64.09B	65.34B	68.37B
Non-Cash Pension Expense	4.46B	-4.79B	-1.22B	-1.55B	-2.8B
Supplemental Operating Expense Items
Selling and Marketing Expenses	25.87B	30.28B	32.64B	30.59B	33.92B
Research And Development Expense From Footnotes	35.11B	37.01B	40.47B	41.7B	44.25B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	87.45B	145B	101B	139B	143B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	87.45B	145B	101B	139B	143B
Accounts Receivable, Total	169B	184B	191B	211B	205B
Notes Receivable	2M	182M	114M	1.12B	714M
Total Receivables	169B	185B	191B	212B	206B
Inventory	223B	244B	287B	298B	314B
Prepaid Expenses	7.12B	8.09B	8.41B	5.79B	7.39B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	18.63B	28.26B	34.43B	30.66B	33.5B
Total Current Assets	506B	609B	622B	686B	703B
Net Property Plant And Equipment	351B	365B	377B	392B	404B
Long-term Investments	189B	165B	167B	181B	159B
Goodwill	50.91B	10.74B	11.03B	8.64B	6.87B
Other Intangibles, Total	46.74B	36B	39.98B	50.46B	52.26B
Loans Receivable Long-Term	1.61B	1.16B	1.16B	1.1B	923M
Deferred Tax Assets Long-Term	5.35B	10.91B	10.03B	4.22B	4.86B
Other Long-Term Assets, Total	1M	2M	1M	1M	2M
Total Assets	1,150B	1,199B	1,228B	1,323B	1,331B
Liabilities
Accounts Payable, Total	118B	138B	137B	124B	124B
Accrued Expenses, Total	61.78B	63.5B	60.73B	63.21B	66.96B
Short-term Borrowings	7.28B	4.29B	3.57B	11.57B	2.34B
Current Portion of Long-Term Debt	-	-	-	30M	-
Current Portion of Leases	4.62B	5B	5.16B	5.43B	5.42B
Current Income Taxes Payable	10.66B	23.68B	11.82B	25.09B	16.87B
Other Current Liabilities	80.35B	95.04B	110B	115B	125B
Total Current Liabilities	282B	330B	328B	345B	340B
Long-Term Debt	111B	98.09B	96.22B	86.27B	86.04B
Long-Term Leases	15.06B	15.17B	15.52B	17.42B	17.02B
Pension & Other Post Retirement Benefits	30.4B	41.84B	42.73B	41.34B	42.82B
Deferred Tax Liability Non Current	10.36B	4.62B	4.05B	4.76B	1.52B
Other Non Current Liabilities	6.45B	6.75B	9.12B	7.93B	8B
Total Liabilities	456B	496B	496B	502B	495B
Common Stock, Total	100B	100B	100B	100B	100B
Additional Paid In Capital	109B	109B	109B	109B	105B
Retained Earnings	441B	448B	468B	502B	545B
Treasury Stock	-43.41B	-44.59B	-46.64B	-48.68B	-50.08B
Comprehensive Income and Other	60.37B	62.22B	74.98B	130B	108B
Total Common Equity	667B	675B	705B	792B	807B
Minority Interest	27.32B	28.12B	27.5B	28.6B	28.02B
Total Equity	694B	703B	733B	821B	835B
Total Liabilities And Equity	1,150B	1,199B	1,228B	1,323B	1,331B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	449M	436M	429M	421M	418M
ECS Total Common Shares Outstanding	449M	444M	429M	421M	418M
Book Value / Share	1.49K	1.52K	1.64K	1.88K	1.93K
Tangible Book Value	569B	628B	654B	733B	748B
Tangible Book Value Per Share	1.27K	1.41K	1.52K	1.74K	1.79K
Total Debt	138B	123B	120B	121B	111B
Net Debt	50.71B	-21.98B	19.38B	-17.85B	-31.76B
Debt Equivalent of Unfunded Proj. Benefit Obligation	29.39B	20.07B	26.44B	4.89B	6.16B
Minority Interest, Total (Incl. Fin. Div)	27.32B	28.12B	27.5B	28.6B	28.02B
Inventories - Raw Materials, Total	34.02B	45.6B	55.95B	56.7B	61.9B
Inventories - Work In Process, Total	50.47B	56.61B	62.6B	61.09B	72.01B
Inventories - Finished Goods, Total	138B	142B	168B	180B	180B
Full Time Employees	26.58K	26.42K	26.84K	26.93K	26.92K
Accumulated Allowance for Doubtful Accounts (Supple)	1.17B	1.26B	965M	776M	686M
Order Backlog	185B	185B	164B	139B	181B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	63.18B	69.86B	99.49B	111B	120B
Depreciation & Amortization - CF	44.93B	45.91B	49B	51.2B	52.36B
Amortization of Goodwill and Intangible Assets - (CF)	4.42B	2.79B	3.41B	1.48B	1.4B
Depreciation & Amortization, Total	49.34B	48.7B	52.41B	52.67B	53.76B
(Gain) Loss From Sale Of Asset	999M	53.05B	2.64B	5.9B	5.04B
(Gain) Loss on Sale of Investments - (CF)	-1.53B	-25.91B	130M	-11.46B	-14.06B
(Income) Loss On Equity Investments - (CF)	-2.75B	-108M	-2.25B	-843M	1.09B
Other Operating Activities, Total	-21.09B	-22.17B	-37.17B	-16.67B	-38.77B
Change In Accounts Receivable	4.63B	-7.29B	-1.55B	-11.36B	4.14B
Change In Inventories	-4.16B	-16.84B	-36.72B	-2.34B	-16.41B
Change In Accounts Payable	-11.25B	13.15B	-5.11B	-17.86B	4.34B
Change in Other Net Operating Assets	-2.1B	-7.43B	-328M	-2.9B	122M
Cash from Operations	75.27B	105B	71.54B	107B	119B
Capital Expenditure	-55.36B	-37B	-44.67B	-46.07B	-58.1B
Sale of Property, Plant, and Equipment	3.94B	1.45B	1.6B	885M	1.34B
Cash Acquisitions	-	-6M	-1.26B	-	-
Divestitures	880M	-	2.78B	17.05B	-
Sale (Purchase) of Intangible assets	-6.71B	-7.62B	-10.64B	-14.38B	-12.21B
Investment in Marketable and Equity Securities, Total	-5.3B	45.96B	-7.4B	25.89B	5.02B
Net (Increase) Decrease in Loans Originated / Sold - Investing	15M	-9M	24M	-917M	445M
Other Investing Activities, Total	4.04B	-81M	132M	-981M	2.01B
Cash from Investing	-58.5B	2.69B	-59.43B	-18.52B	-61.51B
Short Term Debt Issued, Total	-	-	-	407M	-
Long-Term Debt Issued, Total	51.53B	-	502M	5M	707M
Total Debt Issued	51.53B	-	502M	412M	707M
Short Term Debt Repaid, Total	-28.82B	-2.49B	-1.2B	-	-86M
Long-Term Debt Repaid, Total	-3.28B	-13.9B	-2.28B	-2.54B	-10.1B
Total Debt Repaid	-32.1B	-16.4B	-3.48B	-2.54B	-10.18B
Issuance of Common Stock	2.63B	-	-	-	-
Repurchase of Common Stock	-12.2B	-9.5B	-27.41B	-16.17B	-8.92B
Common Dividends Paid	-20.95B	-21.53B	-23.82B	-27.83B	-31.93B
Common & Preferred Stock Dividends Paid	-20.95B	-21.53B	-23.82B	-27.83B	-31.93B
Other Financing Activities, Total	-8.07B	-7.3B	-8.71B	-6.89B	-10.87B
Cash from Financing	-19.16B	-54.73B	-62.91B	-53.02B	-61.2B
Foreign Exchange Rate Adjustments	4.17B	4.06B	2.26B	6.06B	-2.05B
Miscellaneous Cash Flow Adjustments	137M	36M	-	7M	60M
Net Change in Cash	1.93B	57.09B	-48.53B	41.16B	-5.47B
Supplemental Items
Cash Interest Paid	1.19B	790M	872M	1.29B	1B
Cash Income Tax Paid (Refund)	21.5B	23.04B	37.9B	17.26B	39.41B
Levered Free Cash Flow	3.07B	62.44B	-3.02B	32.43B	41.41B
Unlevered Free Cash Flow	3.61B	62.92B	-2.48B	33.12B	42.06B
Change In Net Working Capital	25.73B	-3.28B	56.86B	18.11B	8.85B
Net Debt Issued / Repaid	19.43B	-16.4B	-2.97B	-2.13B	-9.48B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.73	4.73	4.72	4.62	5.08
Return on Total Capital	5.31	6.7	6.83	6.58	7.15
Return On Equity %	6.51	5.55	9.86	10.18	10.16
Return on Common Equity	6.51	5.53	10.04	10.41	10.24
Margin Analysis
Gross Profit Margin %	31.27	30.74	30.36	31.21	32.41
SG&A Margin	20.17	18.64	18.53	19.07	19.4
EBITDA Margin %	11.04	11.88	11.6	11.7	12.46
EBITA Margin %	6.79	7.92	7.65	7.63	8.43
EBIT Margin %	6.37	7.68	7.38	7.51	8.32
Income From Continuing Operations Margin %	4.1	3.35	5.7	6.29	6.48
Net Income Margin %	3.93	3.2	5.57	6.2	6.31
Net Avail. For Common Margin %	3.93	3.2	5.57	6.2	6.31
Normalized Net Income Margin	3.54	5.09	5.16	5.2	5.27
Levered Free Cash Flow Margin	0.29	5.39	-0.24	2.58	3.19
Unlevered Free Cash Flow Margin	0.34	5.43	-0.2	2.64	3.24
Asset Turnover
Asset Turnover	0.94	0.99	1.02	0.98	0.98
Fixed Assets Turnover	3.07	3.23	3.35	3.26	3.26
Receivables Turnover (Average Receivables)	6.17	6.54	6.62	6.25	6.23
Inventory Turnover (Average Inventory)	3.3	3.44	3.26	2.95	2.87
Short Term Liquidity
Current Ratio	1.79	1.85	1.9	1.99	2.07
Quick Ratio	0.91	1	0.89	1.02	1.02
Operating Cash Flow to Current Liabilities	0.27	0.32	0.22	0.31	0.35
Days Sales Outstanding (Average Receivables)	59.11	55.78	55.12	58.55	58.54
Days Outstanding Inventory (Average Inventory)	110.6	106.21	111.92	123.86	127.34
Average Days Payable Outstanding	62.18	56.72	55.21	54.42	50.58
Cash Conversion Cycle (Average Days)	107.53	105.27	111.83	127.99	135.31
Long Term Solvency
Total Debt/Equity	19.9	17.44	16.44	14.71	13.27
Total Debt / Total Capital	16.6	14.85	14.12	12.82	11.71
LT Debt/Equity	18.18	16.12	15.25	12.63	12.34
Long-Term Debt / Total Capital	15.17	13.72	13.1	11.01	10.89
Total Liabilities / Total Assets	39.63	41.38	40.35	37.96	37.23
EBIT / Interest Expense	78.17	114.83	105.24	85.58	104
EBITDA / Interest Expense	135.48	177.76	165.41	133.34	155.79
(EBITDA - Capex) / Interest Expense	71.18	129.96	114.12	91.57	99.81
Total Debt / EBITDA	1.18	0.89	0.84	0.82	0.69
Net Debt / EBITDA	0.43	-0.16	0.13	-0.12	-0.2
Total Debt / (EBITDA - Capex)	2.25	1.22	1.21	1.2	1.07
Net Debt / (EBITDA - Capex)	0.83	-0.22	0.19	-0.18	-0.31
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.44	9.6	7.3	1.13	3.28
Gross Profit, 1 Yr. Growth %	-8.91	7.74	5.98	3.96	7.24
EBITDA, 1 Yr. Growth %	-12.45	17.95	4.72	2.08	9.95
EBITA, 1 Yr. Growth %	-21.21	27.82	3.71	0.84	14.05
EBIT, 1 Yr. Growth %	-23.32	32.06	3.13	2.98	14.36
Earnings From Cont. Operations, 1 Yr. Growth %	-29.01	-10.44	82.58	11.71	6.39
Net Income, 1 Yr. Growth %	-29.5	-10.78	86.86	12.51	5.13
Normalized Net Income, 1 Yr. Growth %	-28.5	57.48	8.75	1.96	4.64
Diluted EPS Before Extra, 1 Yr. Growth %	-28.32	-9.52	91.41	15.26	6.78
Accounts Receivable, 1 Yr. Growth %	-1.9	8.87	3.43	10.68	-2.89
Inventory, 1 Yr. Growth %	2.63	9.39	17.62	3.99	5.23
Net Property, Plant and Equip., 1 Yr. Growth %	4.19	3.94	3.32	4	2.9
Total Assets, 1 Yr. Growth %	4.34	4.24	2.44	7.74	0.57
Tangible Book Value, 1 Yr. Growth %	12.02	10.27	4.16	12.11	2.04
Common Equity, 1 Yr. Growth %	9.47	1.13	4.5	12.38	1.9
Cash From Operations, 1 Yr. Growth %	-18.76	39.53	-31.88	49.05	11.82
Capital Expenditures, 1 Yr. Growth %	5.08	-33.17	20.75	3.12	26.12
Levered Free Cash Flow, 1 Yr. Growth %	-91.9	1.93K	-104.84	-1.17K	27.71
Unlevered Free Cash Flow, 1 Yr. Growth %	-90.59	1.64K	-103.93	-1.44K	27.01
Dividend Per Share, 1 Yr. Growth %	2.17	4.26	20.41	25.42	6.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.84	1.26	8.44	4.17	2.2
Gross Profit, 2 Yr. CAGR %	-5.26	-0.94	6.86	4.97	5.59
EBITDA, 2 Yr. CAGR %	-7.84	1.62	11.14	3.39	5.94
EBITA, 2 Yr. CAGR %	-14.68	0.36	15.14	2.27	7.24
EBIT, 2 Yr. CAGR %	-16.13	0.63	16.71	3.06	8.52
Earnings From Cont. Operations, 2 Yr. CAGR %	-20.5	-20.26	27.88	42.81	9.02
Net Income, 2 Yr. CAGR %	-20.72	-20.69	29.12	45	8.76
Normalized Net Income, 2 Yr. CAGR %	-18.13	6.11	30.86	5.3	3.29
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.44	-19.47	31.6	48.53	10.94
Accounts Receivable, 2 Yr. CAGR %	-4.44	3.34	6.11	6.99	3.67
Inventory, 2 Yr. CAGR %	7.7	5.96	13.43	10.59	4.6
Net Property, Plant and Equip., 2 Yr. CAGR %	6.56	4.07	3.63	3.66	3.45
Total Assets, 2 Yr. CAGR %	6	4.29	3.33	5.06	4.1
Tangible Book Value, 2 Yr. CAGR %	1.15	11.14	7.17	8.06	6.96
Common Equity, 2 Yr. CAGR %	4.81	5.22	2.81	8.37	7.01
Cash From Operations, 2 Yr. CAGR %	-6.01	6.47	-2.51	0.76	29.1
Capital Expenditures, 2 Yr. CAGR %	-4.01	-16.2	-10.17	11.59	14.04
Levered Free Cash Flow, 2 Yr. CAGR %	-70.47	28.3	-0.86	-27.94	270.29
Unlevered Free Cash Flow, 2 Yr. CAGR %	-68.12	28.07	-17.2	-27.45	312.16
Dividend Per Share, 2 Yr. CAGR %	3.35	3.21	12.04	22.89	15.71
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.56	0.44	3.24	5.95	3.87
Gross Profit, 3 Yr. CAGR %	-3.01	-1.11	1.32	5.88	5.72
EBITDA, 3 Yr. CAGR %	-5.37	0.06	2.64	8.03	5.53
EBITA, 3 Yr. CAGR %	-10.97	-2.38	1.46	10.16	6.05
EBIT, 3 Yr. CAGR %	-12.14	-2.43	1.46	11.94	6.69
Earnings From Cont. Operations, 3 Yr. CAGR %	-13.43	-17.28	5.1	22.24	29.46
Net Income, 3 Yr. CAGR %	-13.17	-17.53	5.53	23.33	30.26
Normalized Net Income, 3 Yr. CAGR %	-12.28	1.82	6.98	20.42	5.08
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.71	-16.26	7.48	25.91	33.06
Accounts Receivable, 3 Yr. CAGR %	-2.29	-0.2	3.37	7.62	3.59
Inventory, 3 Yr. CAGR %	9.35	8.26	9.71	10.19	8.77
Net Property, Plant and Equip., 3 Yr. CAGR %	7.9	5.68	3.82	3.75	3.41
Total Assets, 3 Yr. CAGR %	4.8	5.41	3.67	4.78	3.54
Tangible Book Value, 3 Yr. CAGR %	1.98	4.11	8.77	8.79	6.02
Common Equity, 3 Yr. CAGR %	4.29	3.57	4.98	5.9	6.17
Cash From Operations, 3 Yr. CAGR %	-2.92	7.22	-8.26	12.31	4.32
Capital Expenditures, 3 Yr. CAGR %	6.74	-14.92	-5.35	-5.94	16.24
Levered Free Cash Flow, 3 Yr. CAGR %	-41.89	21.02	-56.98	119.34	-12.79
Unlevered Free Cash Flow, 3 Yr. CAGR %	-39.1	20.99	-59.89	109.32	-12.57
Dividend Per Share, 3 Yr. CAGR %	6.42	3.65	8.65	16.34	17.26
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.74	1.67	2.33	1.92	2.82
Gross Profit, 5 Yr. CAGR %	-0.91	0.14	0.82	1.28	3.01
EBITDA, 5 Yr. CAGR %	-1.64	0.61	0.91	1.38	3.95
EBITA, 5 Yr. CAGR %	-4.85	-1.45	-1.33	-0.55	3.74
EBIT, 5 Yr. CAGR %	-5.61	-1.63	-1.57	-0.27	4.23
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.6	-8.94	1.19	2.91	6.65
Net Income, 5 Yr. CAGR %	-6.02	-9.44	1.77	3.35	6.81
Normalized Net Income, 5 Yr. CAGR %	-5.51	0.97	2.94	3.2	5.49
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.36	-7.97	3.57	5.31	8.85
Accounts Receivable, 5 Yr. CAGR %	-0.56	2.52	0.99	2.62	3.49
Inventory, 5 Yr. CAGR %	8.14	9.69	10.97	9.19	7.64
Net Property, Plant and Equip., 5 Yr. CAGR %	5.41	6.89	6.17	4.87	3.67
Total Assets, 5 Yr. CAGR %	4.21	4.91	4.21	5.27	3.84
Tangible Book Value, 5 Yr. CAGR %	3.48	4.24	4.02	5.67	8.04
Common Equity, 5 Yr. CAGR %	4.96	4.18	3.7	5.46	5.79
Cash From Operations, 5 Yr. CAGR %	1.06	-0.6	-2.76	4.59	5.17
Capital Expenditures, 5 Yr. CAGR %	7.01	0.98	-0.38	-5.17	1.98
Levered Free Cash Flow, 5 Yr. CAGR %	-38.22	0.2	-28.04	-1.64	1.77
Unlevered Free Cash Flow, 5 Yr. CAGR %	-36.46	0.23	-31.14	-1.39	1.86
Dividend Per Share, 5 Yr. CAGR %	9.39	7.58	8.63	10.96	11.42